Skip to main content
Views & Reviews
July 1, 1984

Clinical diagnosis of Alzheimer's disease
Report of the NINCDS‐ADRDA Work Group* under the auspices of Department of Health and Human Services Task Force on Alzheimer's Disease

July 1984 issue
34 (7) 939


Clinical criteria for the diagnosis of Alzheimer's disease include insidious onset and progressive impairment of memory and other cognitive functions. There are no motor, sensory, or coordination deficits early in the disease. The diagnosis cannot be determined by laboratory tests. These tests are important primarily in identifying other possible causes of dementia that must be excluded before the diagnosis of Alzheimer's disease may be made with confidence. Neuropsychological tests provide confirmatory evidence of the diagnosis of dementia and help to assess the course and response to therapy. The criteria proposed are intended to serve as a guide for the diagnosis of probable, possible, and definite Alzheimer's disease; these criteria will be revised as more definitive information becomes available.

Get full access to this article

View all available purchase options and get full access to this article.

Information & Authors


Published In

Volume 34Number 7July 1984
Pages: 939
PubMed: 6610841

Publication History

Published online: July 1, 1984
Published in print: July 1984


Request permissions for this article.


Affiliations & Disclosures

Emanuel M. Stadlan, MD

Metrics & Citations



Download Citations

If you have the appropriate software installed, you can download article citation data to the citation manager of your choice. Select your manager software from the list below and click Download.

Cited By
  1. The Diagnostic Challenge of Frontal Alzheimer's Disease: Case Report and Literature Review, European Journal of Medical and Health Research, 2, 1, (145-150), (2024).
  2. Pharmacotherapy for patients with Alzheimer’s disease, Journal of the Korean Medical Association, 67, 3, (213-220), (2024).
  3. Efficacy and safety of chinese herbal medicines combined with chemical drugs for alzheimer's disease: A systematic review and meta-analysis, World Journal of Traditional Chinese Medicine, 10, 1, (1-13), (2024).
  4. Systemic inflammatory markers and their association with Alzheimer’s disease: A cross-sectional analysis, Indian Journal of Psychiatry, 66, 3, (287-292), (2024).
  5. Navigating the Frontiers of Machine Learning in Neurodegenerative Disease Therapeutics, Pharmaceuticals, 17, 2, (158), (2024).
  6. Alzheimer’s Disease Detection Using Deep Learning on Neuroimaging: A Systematic Review, Machine Learning and Knowledge Extraction, 6, 1, (464-505), (2024).
  7. Longitudinal Cognitive Trajectories in Older Adults with Restless Legs Syndrome or Willis–Ekbom Disease, Life, 14, 4, (430), (2024).
  8. Adiponectin Gene Polymorphisms: A Case–Control Study on Their Role in Late-Onset Alzheimer’s Disease Risk, Life, 14, 3, (346), (2024).
  9. Controversial Past, Splendid Present, Unpredictable Future: A Brief Review of Alzheimer Disease History, Journal of Clinical Medicine, 13, 2, (536), (2024).
  10. Comparison of Extracellular Vesicles from Induced Pluripotent Stem Cell-Derived Brain Cells, International Journal of Molecular Sciences, 25, 7, (3575), (2024).
  11. See more

View Options

Get Access

Login options

Check if you have access through your login credentials or your institution to get full access on this article.

Personal login Institutional Login
Purchase Options

Purchase this article to get full access to it.

Purchase Access, $39 for 24hr of access

View options

Full Text

View Full Text







Share article link